chrisvoncsefalvay/vaers-outcomes huggingface dataset:
rt thigh red, swollen from hip to knee, very red;tx ice, atarax, motrin;
Pt described filling body aches, fever, chills, and localized pain to the site about 6 hours after shot was given. The body aches, fever,chills  subsided in less then 24 hours. Patient described it as the sickest he has ever felt in his life. Patient is a family medicine provider at our clinic. He then went on to have pain in his upper arm for a couple weeks which he relates to the injection site.
RASH ON LEFT SIDE OF TRUNK OF BODY LOOK LIKE MOSQUITO BITES AND ON MIDDLE OF BODY; HIVES ON LEFT SIDE OF TRUNK OF BODY LOOK LIKE MOSQUITO BITES AND ON MIDDLE OF BODY; LOW GRADE FEVER; CHILLS; ACHINESS; LAGGY; LETHARGIC; This spontaneous report received from a patient concerned a 64 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821288 expiry: UNKNOWN) dose was not reported, administered on 17-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On 18-JUN-2021, the subject experienced achiness. On 18-JUN-2021, the subject experienced laggy. On 18-JUN-2021, the subject experienced lethargic. On 18-JUN-2021, the subject experienced chills. On 18-JUN-2021, the subject experienced low grade fever. Laboratory data included: Body temperature (NR: not provided) 99 F. Treatment medications included: paracetamol. On 22-JUN-2021, the subject experienced rash on left side of trunk of body look like mosquito bites and on middle of body. On 22-JUN-2021, the subject experienced hives on left side of trunk of body look like mosquito bites and on middle of body. Treatment medications included: camphor/diphenhydramine hydrochloride/zinc oxide. On 23-JUN-2021, treatment medications included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from achiness, laggy, lethargic, chills, and low grade fever on 19-JUN-2021, and was recovering from hives on left side of trunk of body look like mosquito bites and on middle of body, and rash on left side of trunk of body look like mosquito bites and on middle of body. This report was non-serious.
eyelids still swollen; eyes are itchy and red; cancelled second dose; a lot of pain in her left arm; intense pain down to tip of her fingers; eyes swollen shut; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Apr-2021 and was forwarded to Moderna on 09-Apr-2021.    This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Apr-2021 and was forwarded to Moderna on 09-Apr-2021.    This spontaneous case was reported by a  and describes the occurrence of EYE SWELLING (eyes swollen shut), PAIN IN EXTREMITY (a lot of pain in her left arm), PAIN (intense pain down to tip of her fingers), SWELLING OF EYELID (eyelids still swollen) and EYE PRURITUS (eyes are itchy and red) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A27A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced EYE SWELLING (eyes swollen shut). On an unknown date, the patient experienced PAIN IN EXTREMITY (a lot of pain in her left arm), PAIN (intense pain down to tip of her fingers), SWELLING OF EYELID (eyelids still swollen), EYE PRURITUS (eyes are itchy and red) and PRODUCT DOSE OMISSION ISSUE (cancelled second dose). At the time of the report, EYE SWELLING (eyes swollen shut), PAIN IN EXTREMITY (a lot of pain in her left arm), PAIN (intense pain down to tip of her fingers), SWELLING OF EYELID (eyelids still swollen), EYE PRURITUS (eyes are itchy and red) and PRODUCT DOSE OMISSION ISSUE (cancelled second dose) had not resolved. Not applicable      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
pt recvd vax 25JAN93 & devel H. flu bactermia type B SEP93 & H. flu meningitis type B OCT93 which required an 11 day hospitalization; rx'd w/Ceftriaxone & amoxicillin & recovered NOV93;
Co-worker  felt faint and was pale, BP was 93/58. Co-worker reported she has POTS (posterior orthostatic tachycardia) and she reported that she did not take her medication that day. Patient was taken to the emergency room.
3 days after shot I experienced intense chest pain and elevated blood pressure. It seemed like a severe asthma attack.
TIRED/WIPED OUT; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.   On APR-2021, the subject experienced tired/wiped out. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the tired / wiped out was not reported. This report was non-serious. This case, from the same reporter is linked to 20210421077.
Congestion, cough, fatigue for about 7-10 days.   Took Vitamin D3, Vitamin C, Zinc and Tessalon Perles for cough
Patient received combination Flu shot on 01-17-1- at approx. 1PM. Had shot at doctor's office. Had blood drawn at hospital at 1:38PM. After arriving home, deceased complained of being sick to stomach and hot. Began vomiting and had black, runny diarrhea. Overnight patient condition deteriorated, lung filled with fluid and had no pulse when EMS arrived at approx, 12:40 PM 9-18-10. Patient pronounced dead at 1:07 PM on 9-18-10. On 9-18-10 AM before EMS arrived patient vomiting brown bile and had runny, black diarrhea
approx 5-6hrs post vax lt leg had swollen to 2x its nl size;pt upon waking 6AM 23JAN96 w/fever of 104 & was restless,irritable & shrill crying;mom took pt to PMD 830AM & sx were resolving
LATEX  ALLERGY; RASH; TIRED; This spontaneous report received from a patient concerned a 33 year old female. The patient's height, and weight were not reported. The patient's past medical history included drug abuse, and concurrent conditions included penicillin allergy, hives, sulfa allergy, welts, latex allergy, alcoholic, and nonsmoker. The patient was previously treated with metamfetamine for drug abuse. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. Batch number was not reported and has been requested. No concomitant medications were reported. On 09-APR-2021, the subject experienced latex allergy. On 09-APR-2021, the subject experienced rash. On 09-APR-2021, the subject experienced tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from rash, and tired, and the outcome of latex allergy was not reported. This report was non-serious. This case, from the same reporter is linked to 20210425218.
patient felt hot/sweaty and dizzy then passed out for ~5 seconds.  She slumped over, did not fall.  No resulting injury sustained.
Generalized body aches that evening, same day as injection. Woke up the next morning, 12/31/2020 with a headache, fever of 100.2, and fatigue
Site: Pain at Injection Site-Severe, Site: Swelling at Injection Site-Mild, Systemic: Exhaustion / Lethargy-Severe, Systemic: Headache-Mild, Systemic: Unable to Sleep-Severe, Systemic: Weakness-Severe, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-, Additional Details: Patient describes injection site pain as burning. Unable to lift arm or squeeze MD hand. Diagnosed in ED with shoulder injury related to vaccination administration, SIRVA, subacromial bursitis unspecified laterally. Given rxs for Dilaudid, Toradol, ibuprofen and zofran.
This spontaneous report was received from a pharmacist regarding a 28 year old patient of unknown gender. There was no information about concurrent condition and historical medication. On an unknown date the patient was vaccinated with GARDASIL, 0.5 ml, intramuscular, lot no. M014924/ expiration date- 27-MAY-2017, (drug administered to patient of inappropriate age). No adverse event was reported. No concomitant medication was reported. The outcome of the event was unknown. No PQC (product quality complaint) was involved. Additional information has been requested.
02/07/22 presents to EC ED for "Abnormal labs". PMHz of " IgA Goodpasture's disease, CAD s/p CABG, HTN".
Patient presented to waiting room after having COVID 19 vaccine #1, feeling short of breath after 5 minutes in waiting room. Color pale, skin diaphoretic. Laid patient in clinic room bed; BP 142/82 Pulse 60 (Patient avid swimmer)Pulse Oximetry 92%. O2 per nasal cannula at 2L. Patient has leukemia and received monoclonal antibodies last March. Pulse oximetry fluctuated from 92%-97% with O2 on. 911 called and report given and taken to ED per stretcher per ambulance Patient at discharge not short of breath alert and oriented and BP 138/72-62.
This spontaneous report has been received from a Medical Assistant refers to unspecified number of patients of unknown age and gender. Concurrent conditions and pertinent medical history were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB (Lot # K008986 exp. date on 01-APR-2016 and Lot # K021444 exp. date on 17-SEP-2016), (strength, route of administration and dose were not provided). There was no concomitant medication reported. No adverse experiences reported. Product quality complaint was not involved. A phone call was made on 28-SEP-2015 to the reporting Medical Assistant who was no longer with the company. A detailed message was left for supervisor to return the call. This is one of several reports received from the same reporter. Additional information has been requested.
Varicella (3rd dose) given on 3-8-11, mom reported knot developed at site of vaccination later in day after receiving shot. Got progressively larger, measuring 9x12 cm. Area red & warm with blister in center on exam (left arm).
Patient said Friday evening, she had chills. Saturday morning, she started to get nauseated and later was vomiting.  She said flu like symptoms. She said she could not keep anything down all of saturday and sunday. She said she could not eat or drink anything and she could hardly move.  She just now started to feel slightly better. She did not have loose bowel movements.  When asked about shot 2 and 3, she said she had mild flu like symptoms but nothing like what she experience this weekend.
chicken pox erupted 11 days p/vax inj site became red/swollen 9 days p/vax approx 1" diameter x 4 days still apparent 1wk later;
Fever, chills, headache, stomach cramps, nauseous, joint pain, dizziness, pain allover, dehydration severe
Tingling in hands; headache; pain in back muscles; fever; pain at injection site.
Sore arm; Headache; Tiredness; This is a spontaneous report received from a contactable consumer, the patient.   A 51-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot no: unknown) via an unspecified route of administration in the right arm on 19Mar2021 at 09:30 (at the age of 51 years) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not have any known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021, at 15:00 hours, the patient experienced events sore arm, headache and tiredness. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events sore arm, headache and tiredness were recovering at the time of reporting.   No follow-up attempts are needed; Information about lot/batch number cannot be obtained.  Amendment: This follow-up report is being submitted to amend previously reported information: Age and age at vaccination updated from 52 years to 51 years per DOB and event onset time. Final sentence updated as no follow-up attempts are needed; Information about lot/batch number cannot be obtained.
After the MMR, pt had trouble walking, tight legs. Does have lupus chilbain's (?), prior to all this.
4/25/21 - COVID-19 infection: Pneumonia due to COVID-19 virus Reason for admission?patient completed course of remdesivir, plasma therapy. He was treated with IV dexamethasone?changed to oral medicine at the time of discharge.   Patient was requiring 2 to 3 L of oxygen via nasal cannula?we will continue and expect improvement down the road.  4/30/21 - readmitted COVID-19 virus infection
Arthritis-fingers, knees, hips-migrating dibilitating fatigue. Adverse reaction to 3rd Lymerix injection inflammation of upper left arm fever/chills-stiffness in back, knees, hips. Dibilitating pain in hips knees with stiffness. Per medical record, pt experienced cervical spondylosis, degenerative disk dx, and falls.
About 4pm that same day of the vaccine, I developed a 102 fever, chills and body aches. I felt awful for about 24hrs and by the next day all symptoms had subsided. On 1/10/2022, I developed a fever and d/t to the fact my daughter tested positive a couple days prior so I went to the Urgent Care (COVID-19 was test and it was positive).
I had the booster vaccine on October 8th. I then had a lymph node biopsy on October 13th. Within a day or two, I had extreme fatigue, excessive sweating, random fevers, muscle aches, dizziness, seeing spots, nausea, loss of appetite, weakness, general discomfort, swollen glands all over my body, especially the left side where the biopsy was.  It was described to me as an "autoimmune storm". No further testing has been done.  I was prescribed Meloxicam. I needed to take two to feel close to "normal". A follow up phone visit with a different doctor suggested that I try to take just one tablet, but all the symptoms returned. I did that on 11/5/2021, but had to return to taking two. I am still recovering from that on 11/8/2021.  I have been to work four non-consecutive days in the past month.
"half of a cantaloupe" size rash at injection site after vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH ("half of a cantaloupe" size rash at injection site after vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Hypochondriacal personality.In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH ("half of a cantaloupe" size rash at injection site after vaccine). At the time of the report, VACCINATION SITE RASH ("half of a cantaloupe" size rash at injection site after vaccine) outcome was unknown.    Concomitant medications were not reported.Treatment medications were not reported.
Sore arm; fatigue; feeling unwell; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Sore arm"; FATIGUE (non-serious), outcome "unknown", described as "fatigue"; MALAISE (non-serious), outcome "unknown", described as "feeling unwell".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
4 days after receiving the vaccine, I had severe fatigue, hear palpitations, tingling and numbness in my hands and face, anxiety and muscle spasm. I went to the ER and was hospitalized for 24 hours. At the hospital I received multiple tests but it was not discovered was caused my symptoms. Later my Primary Care provider diagnosed me with a B12 deficiency based on the same test results, and treatment with cobalamin injections has been very effective.
pt up 630AM went to bathroom & then became unresponsive w/jerking movements, staring; mom described as in a deep sleep; taken to ER responded p/blood work done (unresponsive 1/2 hr);
Duty-affecting body aches and pains, headache, nausea for  two days after first shot, three days after second.  Persistent low-grade nausea/sour stomach, headache, and aches following second shot until now.
Patient was given a expired TDAP shot expired on 6/1/10 and given on 6/16/10. Called Health Dept and Sanofi and they advised us to regive shot. Follow-up: No adverse reaction - was told to report that staff had given an expired vaccine. Only the TDAP was expired. All the rest of vaccines were fine.
Immediately upon injection I had a painful burning sensation that went completely down to my fingertips. The shot administer told me to rub my arm throughout the day but the pain intensified on through the day and night to a point where I had limited mobility.  I then had to seek help from my family doctor. I was sent to an orthopedic doctor who then sent me to a neurologist who is sending me back to the orthopedic doctor.  I am still under doctor's care at this time.
Body cramps..started early that morning by the time I got to work the cramps were worse.
Pt reported difficulty in swallowing and wife noticed left-sided facial droop morning of 1/10. Patient admitted for concerns of TIA.  Symptoms resolved prior to hospitalization.  Patient had MRI brain without contrast of the find evidence of acute infarct.  Neurology recommended treatment patient has TIA and having dual anti-platelet therapy for 21 days followed by monotherapy of Plavix for stroke prevention.   Patient was stable discharge to home 1/12/21
SEIZURES; This spontaneous report received from a consumer via a company representative via Communication concerned multiple patients. The patient's weight, height, and medical history were not reported. The patients received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry date were not reported) 1 total dose and start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patients died from seizures. It was unspecified if an autopsy was performed.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20230754295- seizures. Insufficient information is available to make a causality assessment. Therefore, this event is considered unclassifiable.; Reported Cause(s) of Death: SEIZURES
Itch; Swelling; Redness; Rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itch), SWELLING (Swelling), ERYTHEMA (Redness) and RASH (Rash) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included POTASSIUM, VITAMIN D3 and OXYMETAZOLINE HYDROCHLORIDE (CLARITIN) for an unknown indication.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced PRURITUS (Itch), SWELLING (Swelling), ERYTHEMA (Redness) and RASH (Rash). At the time of the report, PRURITUS (Itch), SWELLING (Swelling), ERYTHEMA (Redness) and RASH (Rash) outcome was unknown.            Concomitant medication also included blood pressure medication. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.
Clear productive cough, bronchospasms, sore throat one week after (Fluarix vaccine Lot:AFLUA358BA). SYMTOMES STILL PERSIST UP TO TODAY. NO RELIF AFTER 4 DAYS OF LEVAQUIN ABX
A week after receiving the first dose of the Pfizer vaccine, I noticed a bald patch forming on my right temple. Ever since (signing as of 6/25/22) I have very severe Alopecia Areata. I have come to lose 70% of my head at minimum and have been receiving intense treatments on a monthly basis, including Kenalog injections directly on my scalp and oral Minoxidil. The only symptoms I have been showing was hair loss, which means I'm losing clumps of hair on a daily basis, likely averaging 300 hairs a day. Today I have lost all my hair around my hairline, and have patches all over both the back and sides of my head. Additionally, the hair loss has never slowed down. It was getting worse with the Minoxidil, that I have stopped using as of last week. Because of all the medications I've been trying, I have gained 20-30 pounds and have lost my confidence. I have always enjoyed my long hair, and now it is nearly impossible to hide without having to get a wig. Everyday I have immense hair loss, and it continues to scare me to shower, brush my hair and go out in public. I was completely healthy prior to this event.
This case meets criteria for vaccine breakthrough review. Patient admitted for evaluation of weakness and falls.  Asymptomatic of other COVID SxS
Information has been received from a registered nurse concerning a 19 year old female patient with anemia, herpes type 1 since July 2005 and sulfa allergy who on 21-OCT-2008 was vaccinated with her first dose of GARDASIL (lot # 661044/0548X) IM.  The patient experienced "flu like" symptoms after her first vaccine.  On 22-DEC-2008 the patient was vaccinated with her second dose of GARDASIL (lot # 660616/0570X) IM.  Concomitant therapy includes VALTREX and birth control therapy.  After her second vaccine on 22-DEC-2008 the patient experienced nausea and "was flat on her back for 4 days in bed with a low grade fever".  The patient called the office in March 2009 to conceal her appointment for a third dose of GARDASIL citing the previous 2 reactions.  The patient did not call the office when she experienced the reactions.  The patient would not continue the series.  Subsequently the patient recovered.  Additional information has been requested.
Legal report of a male pt who experienced toxic exposure to mercury coincident with Certiva. On an unreported date, the pt was exposed to Certiva therapy. On an unreported date, the pt experienced toxic exposure to mercury, which led to permanent neurological injuries. It was noted that the pt was exposed to mercury from continually inhaling and ingesting mercury emissions. Pertinent laboratory tests, diagnostic procedures, medical history or concomitant medication information was not provided. The pt was a child. The event of toxic exposure to mercury was considered serious.